Cognate BioServices Secures Growth Capital Investment from EW Healthcare to Continue to Expand Commercial Manufacturing Capacity and Services for the Cellular Therapies Industry – PRNewswire
BALTIMORE and MEMPHIS, Tenn., Aug. 26, 2019 /PRNewswire/ — Cognate BioServices, a leading contract development and manufacturing organization …
Source: Investment New Feed